BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding BioCardia, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 25 | 23 | −2 |
| Shares | 2.33M | 2.09M | −238.8K (−10.2%) |
| Value | $4.87M | $4.09M | −$785.1K (−16.1%) |
New holders (1)
Institutions that held BioCardia, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vontobel Holding Ltd. | 15,895 | $31.2K | 0.00% |
Sold out (3)
Institutions that held BioCardia, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 11,536 | $24.0K |
| Simplex Trading, LLC | 7,543 | $15.0K |
| IFP Advisors, Inc | 100 | – |